Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
About this item
Full title
Author / Creator
Publisher
United States: American Medical Association
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Medical Association
Subjects
More information
Scope and Contents
Contents
Some patients treated with nirmatrelvir-ritonavir have experienced rebound of COVID-19 infections and symptoms; however, data are scarce on whether viral rebound also occurs in patients with COVID-19 receiving or not receiving molnupiravir.
To examine the incidence of viral rebound in patients with COVID-19 who were treated with the oral antivir...
Alternative Titles
Full title
Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9856258
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9856258
Other Identifiers
ISSN
2574-3805
E-ISSN
2574-3805
DOI
10.1001/jamanetworkopen.2022.45086
